Ricerca
Didattica
Soluzioni
Accedi
IT
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Breast Surgery Group,
Division of Medical Sciences and Graduate Entry Medicine,
School of Medicine,
Queen's Medical Centre,
Breast Surgery Group, Division of Medical Sciences and Graduate Entry Medicine, School of Medicine, Queen's Medical Centre
Ola H. Negm has not added Biography.
If you are Ola H. Negm and would like to personalize this page please email our Author Liaison for assistance.
TOMM34 expression in early invasive breast cancer: a biomarker associated with poor outcome.
Breast cancer research and treatment Nov, 2012 | Pubmed ID: 23053644
Clinicopathological significance of KU70/KU80, a key DNA damage repair protein in breast cancer.
Breast cancer research and treatment Jun, 2013 | Pubmed ID: 23624778
SUMOylation proteins in breast cancer.
Breast cancer research and treatment Apr, 2014 | Pubmed ID: 24584753
A pro-inflammatory signalome is constitutively activated by C33Y mutant TNF receptor 1 in TNF receptor-associated periodic syndrome (TRAPS).
European journal of immunology Jul, 2014 | Pubmed ID: 24668260
Epithelial mesenchymal transition in early invasive breast cancer: an immunohistochemical and reverse phase protein array study.
Breast cancer research and treatment Jun, 2014 | Pubmed ID: 24771047
Development and validation of protein microarray technology for simultaneous inflammatory mediator detection in human sera.
Mediators of inflammation , 2014 | Pubmed ID: 25382942
The mammalian target of rapamycin complex 1 (mTORC1) in breast cancer: the impact of oestrogen receptor and HER2 pathways.
Breast cancer research and treatment Feb, 2015 | Pubmed ID: 25701120
Clinical and biological significance of glucocorticoid receptor (GR) expression in breast cancer.
Breast cancer research and treatment Apr, 2015 | Pubmed ID: 25762479
Prognostic and biological significance of peroxisome proliferator-activated receptor-gamma in luminal breast cancer.
Breast cancer research and treatment Apr, 2015 | Pubmed ID: 25794775
The novel S59P mutation in the TNFRSF1A gene identified in an adult onset TNF receptor associated periodic syndrome (TRAPS) constitutively activates NF-κB pathway.
Arthritis research & therapy Apr, 2015 | Pubmed ID: 25888769
Profiling Humoral Immune Responses to Clostridium difficile-Specific Antigens by Protein Microarray Analysis.
Clinical and vaccine immunology : CVI Sep, 2015 | Pubmed ID: 26178385
Tumour necrosis factor receptor I blockade shows that TNF-dependent and TNF-independent mechanisms synergise in TNF receptor associated periodic syndrome.
European journal of immunology Oct, 2015 | Pubmed ID: 26202849
Clinical utility of reverse phase protein array for molecular classification of breast cancer.
Breast cancer research and treatment Jan, 2016 | Pubmed ID: 26661092
The mannose receptor negatively modulates the Toll-like receptor 4-aryl hydrocarbon receptor-indoleamine 2,3-dioxygenase axis in dendritic cells affecting T helper cell polarization.
The Journal of allergy and clinical immunology Jun, 2016 | Pubmed ID: 26703454
The prognostic significance of STAT3 in invasive breast cancer: analysis of protein and mRNA expressions in large cohorts.
Breast cancer research and treatment Feb, 2016 | Pubmed ID: 26907764
Human Blood Autoantibodies in the Detection of Colorectal Cancer.
PloS one , 2016 | Pubmed ID: 27383396
Clinical and biological significance of RAD51 expression in breast cancer: a key DNA damage response protein.
Breast cancer research and treatment 08, 2016 | Pubmed ID: 27464795
Clinicopathological and prognostic significance of mitogen-activated protein kinases (MAPK) in breast cancers.
Breast cancer research and treatment Oct, 2016 | Pubmed ID: 27592113
SMAD4 loss enables EGF, TGFβ1 and S100A8/A9 induced activation of critical pathways to invasion in human pancreatic adenocarcinoma cells.
Oncotarget Oct, 2016 | Pubmed ID: 27655713
Peripheral killer cells do not differentiate between asthma patients with or without fixed airway obstruction.
The Journal of asthma : official journal of the Association for the Care of Asthma Jun, 2017 | Pubmed ID: 27736259
The role of indoleamine 2,3-dioxygenase-aryl hydrocarbon receptor pathway in the TLR4-induced tolerogenic phenotype in human DCs.
Scientific reports Mar, 2017 | Pubmed ID: 28256612
High prevalence of subclass-specific binding and neutralizing antibodies against toxins in adult cystic fibrosis sera: possible mode of immunoprotection against symptomatic infection.
Clinical and experimental gastroenterology , 2017 | Pubmed ID: 28765714
A signalome screening approach in the autoinflammatory disease TNF receptor associated periodic syndrome (TRAPS) highlights the anti-inflammatory properties of drugs for repurposing.
Pharmacological research Nov, 2017 | Pubmed ID: 28860008
Autoantibodies of IgM and IgG classes show differences in recognition of multiple autoantigens in chronic obstructive pulmonary disease.
Clinical immunology (Orlando, Fla.) 10, 2017 | Pubmed ID: 28951328
Characterization of Behavioral, Signaling and Cytokine Alterations in a Rat Neurodevelopmental Model for Schizophrenia, and Their Reversal by the 5-HT Receptor Antagonist SB-399885.
Molecular neurobiology Feb, 2018 | Pubmed ID: 29423817
University of Nottingham
Mansoura University
Ola H. Negm1,2,
Mohamed Hamed1,2,
Tanya M. Monaghan3
1Breast Surgery Group, Division of Medical Sciences and Graduate Entry Medicine, School of Medicine, Queen's Medical Centre, University of Nottingham,
2Medical Microbiology and Immunology Department, Faculty of Medicine, Mansoura University,
3Nottingham Digestive Diseases Centre and NIHR Nottingham Digestive Diseases Biomedical Research Centre, School of Medicine, Queen's Medical Centre, University of Nottingham
Riservatezza
Condizioni di utilizzo
Politiche
Contattaci
SUGGERISCI JOVE ALLA BIBLIOTECA
Newsletter di JoVE
JoVE Journal
Raccolta di metodi
JoVE Encyclopedia of Experiments
Archivio
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Sportello unico per docenti
Autori
Personale delle biblioteche
Accesso
CHI SIAMO
Copyright © 2024 MyJoVE Corporation. Tutti i diritti riservati